Mucus como un rasgo tratable en enfermedades crónicas de las vías respiratorias

Área de la Ciencia:

• Pulmonary Medicine
• Respiratory Pathophysiology
• Personalized Medicine

Sus antecedentes:

• Chronic airway diseases (asthma, COPD, bronchiectasis, cystic fibrosis) are complex and heterogeneous.
• Mucus abnormalities significantly contribute to symptoms, airflow limitation, and disease progression.
• Mucus dysfunction is a key phenotype within the 'treatable traits' framework.

Objetivo del estudio:

• To review mucus as a treatable trait in chronic airway diseases.
• To integrate mechanistic insights with clinical assessment and biomarkers.
• To explore current and emerging therapeutic strategies for mucus-related abnormalities.

Principales métodos:

• Narrative review of existing literature.
• Integration of mechanistic understanding of mucus.
• Discussion of clinical assessment, biomarkers, and therapeutics.

Principales resultados:

• Mucus abnormalities are a modifiable phenotype across diverse chronic airway diseases.
• Targeting mucus aligns with precision medicine principles.
• Personalized interventions for mucus can improve patient outcomes.

Conclusiones:

• Mucus is a critical treatable trait in chronic airway diseases.
• Recognizing mucus abnormalities enables individualized therapy.
• This approach moves beyond traditional diagnostic categories for better management.